5Q DELETION/MONOSOMY (MDS)

image not found

NABL Cap Accredited 
The 5q Deletion/Monosomy (MDS) Test at Metropolis Healthcare is a genetic analysis used to detect the deletion of the long arm of chromosome 5 in myelodysplastic syndromes (MDS). This chromosomal abnormality helps doctors classify the type and risk of MDS. Identifying the 5q deletion is important for predicting disease progression and guiding treatment decisions. The test provides insights into the patient’s prognosis and therapy response. It supports personalized management and monitoring of bone marrow disorders.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,195.00

Sample Type: HEPARIN BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
  4. Soft copy reports will be sent to your email address within 24 to 48 hours.

Frequently Asked Questions (FAQ's):

1. What is the 5q Deletion/Monosomy (MDS) Test?
This test identifies the deletion of the long arm of chromosome 5 in patients with myelodysplastic syndromes (MDS) to assess disease type and risk.

2. Why is this test important?
It helps predict disease progression, response to therapy, and guides personalized treatment strategies in MDS patients.

3. Who should undergo this test?
Patients diagnosed with or suspected of having MDS or bone marrow disorders may be advised to take this test for proper disease evaluation.

4. How is the test performed?
At Metropolis Healthcare, the test is done using bone marrow or blood samples, analyzed with advanced cytogenetic techniques for accurate detection.

5. What do the results indicate?
Detection of 5q deletion indicates a specific subtype of MDS, influencing prognosis and treatment plans, while absence suggests other MDS variants.

6. Are there any risks associated with the test?
The test is safe, with minimal risk related mainly to the sample collection procedure.

7. Why choose Metropolis Healthcare for this test?
Metropolis Healthcare provides accurate cytogenetic testing with expert analysis and advanced technology, ensuring reliable results for effective disease management.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab